3 free views remaining today

central nervous system benign neoplasm

ICD-10 Codes

Related ICD-10:

Description

A central nervous system (CNS) benign neoplasm, also known as a noncancerous brain tumor or benign brain tumor, is a type of growth that arises from the CNS and does not have cancer cells. These tumors are characterized by their slow growth and lack of invasive features or metastatic potential.

Key characteristics:

  • Non-cancerous: Benign neoplasms do not have cancer cells and are not malignant.
  • Slow growth: These tumors grow slowly over time, but can still press on surrounding brain tissue.
  • No invasive features: Benign CNS neoplasms do not invade surrounding tissues or organs.
  • No metastatic potential: They do not spread to other parts of the body.

Types of benign CNS neoplasms:

  • Noncancerous brain tumors, such as meningiomas

Additional Characteristics

  • Slow growth
  • Non-cancerous
  • No invasive features
  • No metastatic potential
  • Meningiomas

Signs and Symptoms

Based on the provided context, here are the signs and symptoms of central nervous system (CNS) benign neoplasms:

  • Headaches [1]
  • Seizures [3]
  • Difficulty thinking, speaking, or finding words [3]
  • Changes in personality or behavior [3]
  • Weakness, numbness, or loss of motor function [3]
  • Cysts in the CNS can cause tumor-like symptoms including headache and seizures [4]

It's worth noting that these symptoms may vary depending on the location and size of the neoplasm. Benign brain tumors typically grow slowly, have distinct borders, and rarely spread [7]. However, they can still be dangerous and damage or compress parts of the brain [7].

Symptoms may also include personality changes (such as becoming depressed, anxious, or uninhibited), weakness, abnormal sensations, loss of balance, and other neurological symptoms [8].

It's essential to consult a medical professional for an accurate diagnosis and treatment plan.

Additional Symptoms

  • Seizures
  • Headaches
  • Personality changes
  • Difficulty thinking, speaking, or finding words
  • Changes in personality or behavior
  • Weakness, numbness, or loss of motor function
  • Abnormal sensations
  • weakness
  • headache
  • loss of balance

Diagnostic Tests

Diagnostic Tests for Central Nervous System (CNS) Benign Neoplasms

Diagnosing CNS benign neoplasms, such as meningiomas, requires a combination of physical examination, neurological evaluation, and diagnostic imaging. Here are some of the tests used to diagnose these conditions:

  • Physical Exam: A thorough physical exam is essential to identify any abnormalities in the nervous system (1).
  • Neurological Exam: A neurological exam may include various tests such as checking reflexes, muscle strength, and sensation to assess the function of the nervous system (9).
  • Diagnostic Imaging:
    • Computed Tomography (CT) Scan: A CT scan uses X-rays and a computer to take pictures of the head or body. It can help identify tumors in the CNS (5).
    • **

Additional Diagnostic Tests

  • Physical Exam
  • Neurological Exam
  • MRI Scan

Treatment

Treatment Options for Central Nervous System Benign Neoplasms

Central nervous system (CNS) benign neoplasms, also known as benign tumors, can be treated with various methods to manage symptoms and prevent complications. The treatment options depend on the type and location of the tumor.

  • Surgical Resection: Surgical removal of the tumor is often considered the definitive treatment for CNS benign neoplasms, such as meningioma, pituitary neuroendocrine tumors (PitNET), and schwannoma [6]. This approach can be curative in many cases.
  • Monitoring: Small benign tumors may not require immediate treatment and can be monitored with regular check-ups to ensure they do not grow or cause any symptoms [3].
  • Targeted Therapy: Targeted therapy is a type of treatment that uses drugs or other substances to identify and attack specific cancer cells. This approach may be used in combination with surgery or radiation therapy for CNS benign neoplasms [1].

Additional Considerations

It's essential to note that the treatment plan should be individualized based on the patient's overall health, age, and tumor characteristics.

  • Chemotherapy: Chemotherapy is not typically used as a primary treatment for CNS benign neoplasms, but it may be considered in certain cases [2].
  • Radiation Therapy: Radiation therapy can be used to treat some types of CNS benign neoplasms, such as meningioma, but its use depends on the tumor's location and size [4].

References

[1] Adult central nervous system tumor treatment may include surgery, radiosurgery, radiation therapy, chemotherapy, surveillance, and targeted therapy. Treatment depends on the tumor type.

[2] Adult central nervous system tumor treatment options include surgery, radiosurgery, radiation therapy, chemotherapy, surveillance, and supportive care.

[3] Malignant tumors require some form of treatment, while some small benign tumors may need only monitoring.

[4] This page lists cancer drugs approved by the FDA for use in brain tumors.

[6] Surgical resection represents the definitive treatment for benign tumors of the central nervous system (BTCNS).

Recommended Medications

  • Chemotherapy
  • Targeted Therapy

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Understanding Differential Diagnosis in Central Nervous System Benign Neoplasms

Differential diagnosis refers to the process of distinguishing between different possible causes or conditions that may explain a patient's symptoms or test results. In the context of central nervous system (CNS) benign neoplasms, differential diagnosis is crucial for accurate diagnosis and treatment.

Types of CNS Benign Neoplasms

There are several types of CNS benign neoplasms, including:

  • Gliomas: These are tumors that arise from the brain's glial cells. They can be further classified into different subtypes, such as pilocytic astrocytoma and ependymoma.
  • Meningiomas: These are tumors that arise from the meninges, which are the protective membranes surrounding the brain and spinal cord.
  • Schwannomas: These are tumors that arise from the Schwann cells, which are responsible for myelinating nerve fibers.

Differential Diagnosis of CNS Benign Neoplasms

The differential diagnosis of CNS benign neoplasms involves considering various conditions that may mimic or be confused with these types of tumors. Some of the key considerations include:

  • Reactive gliosis: This is a condition in which the brain's glial cells become activated and proliferate in response to injury or inflammation.
  • Infections: Certain infections, such as abscesses or encephalitis, can mimic the symptoms of CNS benign neoplasms.
  • Vascular malformations: These are abnormal connections between blood vessels that can cause symptoms similar to those of CNS benign neoplasms.

Importance of Accurate Diagnosis

Accurate diagnosis is critical for effective treatment and management of CNS benign neoplasms. A misdiagnosis or delayed diagnosis can lead to inappropriate treatment, worsening of symptoms, and even death.

According to [3], the differential diagnosis of intracranial tumors (ICTs) is a dubious task that requires a highly trained neuropathologist and a set of both clinical and radiological criteria. Similarly, [4] notes that the most important differential diagnosis of glioma is reactive gliosis or reactive astrocytosis.

In conclusion, differential diagnosis plays a crucial role in the accurate diagnosis and treatment of CNS benign neoplasms. A thorough understanding of the different types of tumors and conditions that may mimic them is essential for effective management and treatment.

References:

[1] by AI Baba · 2007 · Cited by 6 — Microscopically, the following types can be differentiated: the fibrillary type, which is the most frequent; the protoplasmic type; the gemistocytic type; and ...

[3] by GS Stoyanov · 2019 · Cited by 10 — The differential diagnosis (DD) of intracranial tumors (ICTs) is a dubious task that requires a highly trained neuropathologist and a set of both clinical and radiological criteria.

[4] by AI Baba · 2007 · Cited by 6 — The most important differential diagnosis of glioma is reactive gliosis or reactive astrocytosis.

Additional Differential Diagnoses

  • Infections
  • Meningiomas
  • Gliomas
  • Schwannomas
  • Reactive gliosis
  • Vascular malformations

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#created_by
lschriml
oboInOwl#creation_date
2011-07-14T01:45:15Z
oboInOwl#id
DOID:0060090
core#notation
DOID:0060090
IAO_0000115
A nervous system benign neoplasm that is characterized by lack of malignancy.
rdf-schema#label
central nervous system benign neoplasm
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_8331
relatedICD
http://example.org/icd10/D33.9
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
owl#equivalentClass
t336299
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_1121
owl#annotatedSource
t336253

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.